217 related articles for article (PubMed ID: 19008098)
1. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
Pichota A; Duraiswamy J; Yin Z; Keller TH; Alam J; Liung S; Lee G; Ding M; Wang G; Chan WL; Schreiber M; Ma I; Beer D; Ngew X; Mukherjee K; Nanjundappa M; Teo JW; Thayalan P; Yap A; Dick T; Meng W; Xu M; Koehn J; Pan SH; Clark K; Xie X; Shoen C; Cynamon M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6568-72. PubMed ID: 19008098
[TBL] [Abstract][Full Text] [Related]
2. Peptide deformylase inhibitors as potent antimycobacterial agents.
Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv.
Sharma A; Sharma S; Khuller GK; Kanwar AJ
Int J Antimicrob Agents; 2009 Sep; 34(3):226-30. PubMed ID: 19505802
[TBL] [Abstract][Full Text] [Related]
4. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
5. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis.
Sharma A; Khuller GK; Kanwar AJ; Sharma S
J Infect; 2010 Jun; 60(6):498-501. PubMed ID: 20346970
[No Abstract] [Full Text] [Related]
7. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
8. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
[TBL] [Abstract][Full Text] [Related]
9. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
Gokhale KM; Telvekar VN
Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
12. BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosis.
Cynamon MH; Alvirez-Freites E; Yeo AE
J Antimicrob Chemother; 2004 Feb; 53(2):403-5. PubMed ID: 14688038
[No Abstract] [Full Text] [Related]
13. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
[TBL] [Abstract][Full Text] [Related]
14. N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D
Bioorg Med Chem Lett; 2007 Apr; 17(7):1888-91. PubMed ID: 17276683
[TBL] [Abstract][Full Text] [Related]
15. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C
J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742
[TBL] [Abstract][Full Text] [Related]
16. Glycine in the conserved motif III modulates the thermostability and oxidative stress resistance of peptide deformylase in Mycobacterium tuberculosis.
Narayanan SS; Sokkar P; Ramachandran M; Nampoothiri KM
FEMS Microbiol Lett; 2011 Jul; 320(1):40-7. PubMed ID: 21507054
[TBL] [Abstract][Full Text] [Related]
17. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
18. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
19. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
20. Antitubercular potential of plants: a brief account of some important molecules.
Negi AS; Kumar JK; Luqman S; Saikia D; Khanuja SP
Med Res Rev; 2010 Jul; 30(4):603-45. PubMed ID: 19626592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]